EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

The effect of combining antibiotics on resistance: A systematic review and meta-analysis

Berit Siedentop iD, Viacheslav N Kachalov iD, Christopher Witzany iD, Matthias Egger iD, Roger D Kouyos iD, Sebastian Bonhoeffer iD

eLife · 20.12.2024 · 13

DOI: 10.7554/elife.93740 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift eLife, online erschienen am 20.12.2024. Verfasst von Berit Siedentop und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Integrative Biology, Department of Environmental Systems Science, ETH Zürich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacterial Infections, Drug Resistance, Bacterial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, National Institute of Allergy and Infectious Diseases, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Under which conditions antibiotic combination therapy decelerates rather than accelerates resistance evolution is not well understood. We examined the effect of combining antibiotics on within-patient resistance development across various bacterial pathogens and antibiotics.

Methods

We searched CENTRAL, EMBASE, and PubMed for (quasi)-randomised controlled trials (RCTs) published from database inception to 24 November 2022. Trials comparing antibiotic treatments with different numbers of antibiotics were included. Patients were considered to have acquired resistance if, at the follow-up culture, a resistant bacterium (as defined by the study authors) was detected that had not been present in the baseline culture. We combined results using a random effects model and performed meta-regression and stratified analyses. The trials’ risk of bias was assessed with the Cochrane tool.

Results

42 trials were eligible and 29, including 5054 patients, qualified for statistical analysis. In most trials, resistance development was not the primary outcome and studies lacked power. The combined odds ratio for the acquisition of resistance comparing the group with the higher number of antibiotics with the comparison group was 1.23 (95% CI 0.68–2.25), with substantial between-study heterogeneity ( I 2 =77%). We identified tentative evidence for potential beneficial or detrimental effects of antibiotic combination therapy for specific pathogens or medical conditions.

Conclusions

The evidence for combining a higher number of antibiotics compared to fewer from RCTs is scarce and overall compatible with both benefit or harm. Trials powered to detect differences in resistance development or well-designed observational studies are required to clarify the impact of combination therapy on resistance. Funding: Support from the Swiss National Science Foundation (grant 310030B_176401 (SB, BS, CW), grant 32FP30-174281 (ME), grant 324730_207957 (RDK)) and from the National Institute of Allergy and Infectious Diseases (NIAID, cooperative agreement AI069924 (ME)) is gratefully acknowledged.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacterial InfectionsDrug Resistance, BacterialHumansDrug Therapy, CombinationBacteriaRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

antibiotic resistancecombination therapyhumaninfectious diseasemedicinemeta-analysismicrobiologyresistance evolutionsystematic review

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Institute of Integrative Biology, Department of Environmental Systems Science, ETH Zürich, Zurich, Switzerland.
  • Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Population Health Sciences, University of Bristol, Bristol, United Kingdom.
  • Centre for Infectious Disease Epidemiology and Research, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

ORCID-Profile: Berit Siedentop, Viacheslav N Kachalov, Christopher Witzany, Matthias Egger, Roger D Kouyos, Sebastian Bonhoeffer

Förderung

  • Swiss National Science Foundation
  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS

Zitieren

APA

Siedentop, B., Kachalov, V. N., Witzany, C., Egger, M., Kouyos, R. D., & Bonhoeffer, S. (2024). The effect of combining antibiotics on resistance: A systematic review and meta-analysis. eLife, 13. https://doi.org/10.7554/elife.93740

Vancouver

Siedentop B, Kachalov VN, Witzany C, Egger M, Kouyos RD, Bonhoeffer S. The effect of combining antibiotics on resistance: A systematic review and meta-analysis. eLife. 2024;13. doi:10.7554/elife.93740

BibTeX
@article{Siedentop2024,
  author = {Siedentop, Berit and Kachalov, Viacheslav N and Witzany, Christopher and Egger, Matthias and Kouyos, Roger D and Bonhoeffer, Sebastian},
  title = {The effect of combining antibiotics on resistance: A systematic review and meta-analysis},
  journal = {eLife},
  year = {2024},
  volume = {13},
  doi = {10.7554/elife.93740}
}
Kostenlos starten →